The 2018 Ocular Oncogenesis and Oncology Conference will take place at the Champalimaud Centre for the Unknown from July 18th-21st in Lisbon, Portugal.
This conference — held in partnership with the Champalimaud Foundation and hosted at the Champalimaud Centre for the Unknown, its state-of-the-art treatment and research facility in Lisbon, Portugal — will cover the latest basic and clinical research developments in ocular oncogenesis and oncology, and consider them in the context of the systemic cancer field.
The scientific program will focus on malignant tumors of the eye, including: choroidal malignant melanoma, retinoblastoma and primary vitreoretinal lymphoma, and will cover:
The conference will include podium sessions, with opening and closing keynote lectures, a tour of the Champalimaud Centre for the Unknown, poster sessions and multiple opportunities for attendees to network. Speakers will be international experts in oncogenesis and oncology, from the Champalimaud Centre for the Unknown and other ophthalmic centers around the globe.
The UM Cure 2020 Project will organize a special session at the end of the meeting for patients and patient advocates with a networking lunch and a short session Saturday afternoon, 21st July. This session intends to bring patients, clinicians and researchers together in an informal meeting to give space to discussion and time for questions outside the medical office or research workbench. This will be a great opportunity to bring the OM/UM community closer. We would be very happy to count on your presence!
More information, including the program and registration can be found online here. Patients will have a special registry price of $50. Feel free to contact us directly for help with travel and accommodation arrangements (firstname.lastname@example.org).